BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
BrainsWay (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced it will report its fourth quarter and full year 2024 financial results on March 11, 2025, before the U.S. financial markets open.
The company will also provide operational highlights during the announcement. A conference call and webcast will be held at 8:30 AM Eastern Time to discuss these results and provide a business update. The live broadcast will be available on the company's website and will remain accessible for replay for 30 days.
BrainsWay (NASDAQ & TASE: BWAY), un leader globale nei trattamenti avanzati di neurostimolazione non invasiva per i disturbi della salute mentale, ha annunciato che presenterà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 l'11 marzo 2025, prima dell'apertura dei mercati finanziari statunitensi.
Durante l'annuncio, l'azienda fornirà anche i punti salienti operativi. Una conferenza telefonica e un webcast si terranno alle 8:30 AM ora orientale per discutere di questi risultati e fornire un aggiornamento aziendale. La trasmissione in diretta sarà disponibile sul sito web dell'azienda e rimarrà accessibile per la riproduzione per 30 giorni.
BrainsWay (NASDAQ & TASE: BWAY), un líder global en tratamientos avanzados de neuroestimulación no invasiva para trastornos de salud mental, anunció que reportará sus resultados financieros del cuarto trimestre y del año completo 2024 el 11 de marzo de 2025, antes de la apertura de los mercados financieros de EE. UU.
La compañía también proporcionará aspectos destacados operativos durante el anuncio. Se llevará a cabo una conferencia telefónica y una transmisión web a las 8:30 AM hora del Este para discutir estos resultados y ofrecer una actualización empresarial. La transmisión en vivo estará disponible en el sitio web de la empresa y se podrá acceder para su reproducción durante 30 días.
BrainsWay (NASDAQ & TASE: BWAY), 정신 건강 장애를 위한 비침습적 신경 자극 치료의 글로벌 선두주자로, 2024년 4분기 및 연간 재무 결과를 2025년 3월 11일 미국 금융 시장이 열리기 전에 발표할 것이라고 발표했습니다.
회사는 발표 중 운영 하이라이트도 제공할 것입니다. 이 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 동부 표준시 기준 오전 8시 30분에 전화 회의 및 웹캐스트가 진행됩니다. 생방송은 회사 웹사이트에서 이용 가능하며 30일 동안 재생할 수 있습니다.
BrainsWay (NASDAQ & TASE: BWAY), un leader mondial dans les traitements avancés de neurostimulation non invasive pour les troubles de la santé mentale, a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le 11 mars 2025, avant l'ouverture des marchés financiers américains.
L'entreprise fournira également des points saillants opérationnels lors de l'annonce. Une conférence téléphonique et un webinaire auront lieu à 8h30, heure de l'Est, pour discuter de ces résultats et fournir une mise à jour sur les affaires. La diffusion en direct sera disponible sur le site web de l'entreprise et restera accessible en replay pendant 30 jours.
BrainsWay (NASDAQ & TASE: BWAY), ein globaler Marktführer in fortschrittlichen nicht-invasiven Neurostimulationstherapien für psychische Gesundheitsstörungen, gab bekannt, dass es am 11. März 2025, bevor die US-Finanzmärkte öffnen, seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 bekannt geben wird.
Das Unternehmen wird während der Bekanntgabe auch betriebliche Höhepunkte präsentieren. Eine Telefonkonferenz und ein Webcast finden um 8:30 Uhr Eastern Time statt, um diese Ergebnisse zu besprechen und ein Update zum Geschäft zu geben. Die Live-Übertragung wird auf der Unternehmenswebsite verfügbar sein und bleibt 30 Tage lang für die Wiederholung zugänglich.
- None.
- None.
BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its fourth quarter and full year 2024 financial results, as well as operational highlights, before the open of the U.S. financial markets on Tuesday, March 11, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast Information
| Date: | Tuesday, March 11, 2025 |
| Time: | 8:30 AM Eastern Time |
| United States: | 1-877-300-8521 |
| International: | 1-412-317-6026 |
| Israel: | 1-80-921-2373 |
| Conference ID: | 10196869 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1707646&tp_key=bc6ba78957 |
The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in Israel and the U.S., BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
When will BrainsWay report its Q4 and full year 2024 financial results?
What time is BrainsWay's conference call on March 11, 2025?
Where can I access BrainsWay's financial results webcast?
What will BrainsWay discuss in the March 11, 2025 conference call?
